Archive
Gauteng’s medical negligence payouts soar 36%
Gauteng’s medical negligence payouts surged 36% to R696m in 2023/24, deepening the province’s healthcare crisis amid corruption scandals and systemic failures.
Read More
Health Minister must address causes of medical negligence
To reform SA’s troubled healthcare system, the Health Minister must tackle fraudulent claims and hold provincial health departments accountable.
Read More
Safeguarding medical scheme members amid economic challenges
The CMS Annual Report 2023/24 highlights its commitment to protecting medical scheme members, achieving 86% of strategic goals, and resolving 93% of complaints.
Read More
Duo bag Nobel prize for medicine for discovery of microRNA
US scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Medicine for discovering microRNA’s crucial role in gene regulation, cell development.
Read More
Substantial contribution hikes could bolster NHI support
Bestmed warns that rising medical scheme contributions risk alienating younger members and bolstering NHI support. Bestmed proposes a 12.75% increase.
Read More
Closure of drug rehab centres leaves many without support
The closure of Life Nkanyisa’s drug rehab centres in Gauteng leaves a significant gap in substance abuse treatment for over 600 patients.
Read More
Rising rates of cancer in young adults: A concerning trend
This rise is part of a broader trend in early-onset cancers, including breast and pancreatic cancers, sparking serious concerns among global health experts.
Read More
HIV treatment success: Sustaining lifelong care is key
People with HIV on treatment can expect a similar life expectancy as the HIV-negative. Addressing treatment disengagement is vital to ending HIV transmission.
Read More
WHO approves first emergency use Mpox diagnostic test
WHO approves Abbott’s Alinity m mpox diagnostic test for emergency use, enhancing testing in outbreak regions. The PCR test detects the virus from skin swabs.
Read More
Nkengasong calls for collaboration to secure ARV production
Pepfar’s role in boosting local ARV production in Africa, ensuring stable market demand and global acceptance.
Read More
Thoughts on health systems and the future of NHI
Professor Lucy Gilson offers insights into health systems, human relationships, the impact of the NHI Act, and her vision for improving healthcare in SA.
Read More
Gilead grants licenses for generic HIV drug production
Gilead Sciences has granted royalty-free licenses to six generic drug manufacturers for the HIV prevention drug lenacapavir in 120 low-income countries.
Read More